OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Science is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)

Article	Citations
Reactive oxygen species in cancer: Current findings and future directions	343
Pyroptosis, a new bridge to tumor immunity	123
Icariin‐induced inhibition of SIRT6/NF‐κB triggers redox mediated apoptosis and enhances anti‐tumor immunity in triple‐negative breast cancer	102
CAR‐NK cell in cancer immunotherapy; A promising frontier	89
Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors	85
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells	83
CIRCULATE‐Japan: Circulating tumor DNA–guided adaptive platform trials to refine adjuvant therapy for colorectal cancer	82
Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2‐targeting Ab–drug conjugate, in monkeys	74
Ferroptosis‐related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma	72
Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma	70
The roles and regulation of the KLF5 transcription factor in cancers	60
Clonal hematopoiesis and associated diseases: A review of recent findings	57
Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial	56
Gut‐liver axis‐mediated mechanism of liver cancer: A special focus on the role of gut microbiota	55
The gut microbiota associated with high‐Gleason prostate cancer	54
Tumor‐homing peptide and its utility for advanced cancer medicine	54
Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs	53
The noncanonical role of EZH2 in cancer	51
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells	51
Amino acid transporters as emerging therapeutic targets in cancer	50
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab	49
IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism	48
H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA‐519d‐3p/lactate dehydrogenase A axis	48
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma	48
SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/SLC7A11/GPX4 signaling	47

Immune infiltration profiling in gastric cancer and their clinical implications	45
Establishment and implementation of Cancer Genomic Medicine in Japan	45
Enhanced anti‐tumor effects of the PD‐1 blockade combined with a highly absorptive form of curcumin targeting STAT3	44
Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice	43
Low‐dose decitabine plus venetoclax is safe and effective as post‐transplant maintenance therapy for high‐risk acute myeloid leukemia and myelodysplastic syndrome	43
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples	42
PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8⁺ T cell exhaustion during metastasis	42
Proteomic analysis of urinary and tissue‐exudative extracellular vesicles to discover novel bladder cancer biomarkers	42
Real‐world data on NGS using the Oncomine DxTT for detecting genetic alterations in non‐small‐cell lung cancer: WJOG13019L	41
Regulation of vascular permeability in cancer metastasis	41
The heterogeneity of cancer‐associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment	41
Long noncoding RNA just proximal to X‐inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A‐dependent manner in gli	40
Concomitant overexpression of mir‐182‐5p and mir‐182‐3p raises the possibility of IL‐17–producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta‐analysis and experime	39
Aptamer‐based biosensors and application in tumor theranostics	39
Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study	39
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study	38
Methyltransferase‐like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1	38
Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies	38
Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine	37
Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan	36
Personalized cancer vaccination in head and neck cancer	35
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non‐small‐cell lung cancer patients	35
SCRUM‐Japan GI‐SCREEN and MONSTAR‐SCREEN: Path to the realization of biomarker‐guided precision oncology in advanced solid tumors	34
Gastric cancer–secreted exosomal X26nt increases angiogenesis and vascular permeability by targeting VE‐cadherin	34
Using protein microarray to identify and evaluate autoantibodies to tumor‐associated antigens in ovarian cancer	34
Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis	34
Tertiary lymphoid structures show infiltration of effective tumor‐resident T cells in gastric cancer	34
m6A modification–mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability	34
Exosome‐delivered miR‐221/222 exacerbates tumor liver metastasis by targeting SPINT1 in colorectal cancer	34
PTBP1‐targeting microRNAs regulate cancer‐specific energy metabolism through the modulation of PKM1/M2 splicing	33
Pembrolizumab plus pemetrexed‐platinum for metastatic nonsquamous non–small‐cell lung cancer: KEYNOTE‐189 Japan Study	33
Selective autophagy	33
The role of Hippo‐YAP signaling in squamous cell carcinomas	33
α‐Emitting cancer therapy using ²¹¹At‐AAMT targeting LAT1	33
Microbial metabolite deoxycholic acid promotes vasculogenic mimicry formation in intestinal carcinogenesis	32
Multi‐miRNA panel of tumor‐derived extracellular vesicles as promising diagnostic biomarkers of early‐stage breast cancer	32
TET2: A cornerstone in normal and malignant hematopoiesis	32
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers	32
Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines	31
Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma	31
Role of tumor‐associated macrophages at the invasive front in human colorectal cancer progression	31
Clinical use of machine learning‐based pathomics signature for diagnosis and survival prediction of bladder cancer	30
PD‐L1+ dendritic cells in the tumor microenvironment correlate with good prognosis and CD8+ T cell infiltration in colon cancer	30
MiR‐320b/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling	30
New horizons of DNA adductome for exploring environmental causes of cancer	30
Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application	30
M⁶A demethylase fat mass and obesity‐associated protein regulates cisplatin resistance of gastric cancer by modulating autophagy activation through ULK1	30
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer	29
CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR‐145‐5p and regulating TBX15 expression	29
Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: A comprehensive review	29

Body mass index and colorectal cancer risk: A Mendelian randomization study	29
Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma	29
IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients	29
Tumor‐associated macrophage‐derived transforming growth factor‐β promotes colorectal cancer progression through HIF1‐TRIB3 signaling	28
E2F1‐mediated AUF1 upregulation promotes HCC development and enhances drug resistance via stabilization of AKR1B10	28
The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis	28
OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress	28
Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T‐cell lymphoma	28
The BAFF/NFκB axis is crucial to interactions between sorafenib‐resistant HCC cells and cancer‐associated fibroblasts	28
A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma	28
TH1902, a new docetaxel‐peptide conjugate for the treatment of sortilin‐positive triple‐negative breast cancer	28
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab	28
Methyl CpG binding protein 2 promotes colorectal cancer metastasis by regulating N⁶‐methyladenosine methylation through methyltransferase‐like 14	28
Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers	27
CEMIP promotes extracellular matrix‐detached prostate cancer cell survival by inhibiting ferroptosis	27
Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer	27
Nasopharyngeal cancer cell‐derived exosomal PD‐L1 inhibits CD8+ T‐cell activity and promotes immune escape	27
Exosomes from M1‐polarized macrophages promote apoptosis in lung adenocarcinoma via the miR‐181a‐5p/ETS1/STK16 axis	26
Differential glycosylation of collagen modulates lung cancer stem cell subsets through β1 integrin‐mediated interactions	26
hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR‐139‐3p/CCL5 axis	26
Retracted: Arecoline induces epithelial‐mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression	26
Characteristics of B lymphocyte infiltration in HPV⁺ head and neck squamous cell carcinoma	25
Collective cancer cell invasion in contact with fibroblasts through integrin‐α5β1/fibronectin interaction in collagen matrix	25
Nanomedicine targets iron metabolism for cancer therapy	25
Ibrutinib improves the efficacy of anti‐CD19‐CAR T‐cell therapy in patients with refractory non‐Hodgkin lymphoma	25
Curcumin analog B14 has high bioavailability and enhances the effect of anti‐breast cancer cells in vitro and in vivo	24
High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma	24
Landscape of immune cell infiltration in clear cell renal cell carcinoma to aid immunotherapy	24
Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer	24
Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma	24
Azithromycin enhances the cytotoxicity of DNA‐damaging drugs via lysosomal membrane permeabilization in lung cancer cells	24
A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese	24
Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2γ	24
Anti‐tumor efficacy of human anti‐c‐met CAR‐T cells against papillary renal cell carcinoma in an orthotopic model	24
Preclinical and clinical advances in dual‐target chimeric antigen receptor therapy for hematological malignancies	23
Curcumin analog GO‐Y030 boosts the efficacy of anti‐PD‐1 cancer immunotherapy	23
Comprehensive genomic profiling for patients with chemotherapy‐naïve advanced cancer	23
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer	23
LncRNA BASP1‐AS1 interacts with YBX1 to regulate Notch transcription and drives the malignancy of melanoma	23
Utility of the Ba/F3 cell system for exploring on‐target mechanisms of resistance to targeted therapies for lung cancer	23
Water‐soluble dietary fiber alleviates cancer‐induced muscle wasting through changes in gut microenvironment in mice	23
HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression	23
SLC3A2 promotes tumor‐associated macrophage polarization through metabolic reprogramming in lung cancer	23
Omental cancer‐associated fibroblast‐derived exosomes with low microRNA‐29c‐3p promote ovarian cancer peritoneal metastasis	23
The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation	22
Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing	22
Cell‐to‐cell contact‐mediated regulation of tumor behavior in the tumor microenvironment	22
Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy	22
LS‐106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo	22
Sustained and targeted delivery of siRNA/DP7‐C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy	22
Mannose and phosphomannose isomerase regulate energy metabolism under glucose starvation in leukemia	22
Tet2 deficiency in immune cells exacerbates tumor progression by increasing angiogenesis in a lung cancer model	22
HIF‐1α downregulation of miR‐433‐3p in adipocyte‐derived exosomes contributes to NPC progression via targeting SCD1	22
Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer	22
Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypes	22
Current status and future outlook for patient‐derived cancer models from a rare cancer research perspective	22
Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world	22
The Warburg effect as a therapeutic target for bladder cancers and intratumoral heterogeneity in associated molecular targets	22
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma	22
Methylation of NRN1 is a novel synthetic lethal marker of PI3K‐Akt‐mTOR and ATR inhibitors in esophageal cancer	22
lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2‐mediated PI3K/AKT pathway in glioma	21
Bromodomain‐containing protein 4 inhibitor JQ1 promotes melanoma cell apoptosis by regulating mitochondrial dynamics	21
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2	21
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor	21
Effect of fasting on cancer: A narrative review of scientific evidence	21
MCM10 compensates for Myc‐induced DNA replication stress in breast cancer stem‐like cells	21
circ_100984‐miR‐432‐3p axis regulated c‐Jun/YBX‐1/β‐catenin feedback loop promotes bladder cancer progression	21
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients	21
Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer	21
Tissue factor and its procoagulant activity on cancer‐associated thromboembolism in pancreatic cancer	21
LINC01123 enhances osteosarcoma cell growth by activating the Hedgehog pathway via the miR‐516b‐5p/Gli1 axis	21
Urinary malate dehydrogenase 2 is a new biomarker for early detection of non‐small‐cell lung cancer	21
Phase 1 study of tazemetostat in Japanese patients with relapsed or refractory B‐cell lymphoma	21
Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20‐CCR6 pathway	21
miR‐3184‐3p enriched in cerebrospinal fluid exosomes contributes to progression of glioma and promotes M2‐like macrophage polarization	20
HPV⁺ HNSCC‐derived exosomal miR‐9‐5p inhibits TGF‐β signaling‐mediated fibroblast phenotypic transformation through NOX4	20
An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth	20
Human papillomavirus vaccine to prevent cervical intraepithelial neoplasia in Japan: A nationwide case‐control study	20
Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial	20
ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21	20

Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation	20
Tumor endothelial cell‐induced CD8⁺ T‐cell exhaustion via GPNMB in hepatocellular carcinoma	20
AUP1 regulates lipid metabolism and induces lipid accumulation to accelerate the progression of renal clear cell carcinoma	20
Current status of photodynamic technology for urothelial cancer	20
Melatonin inhibits EMT and PD‐L1 expression through the ERK1/2/FOSL1 pathway and regulates anti‐tumor immunity in HNSCC	20
CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma	20
CD109 regulates in vivo tumor invasion in lung adenocarcinoma through TGF‐β signaling	20
Oral histone deacetylase inhibitor tucidinostat (HBI‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results	20
Phase I study of the irreversible fibroblast growth factor receptor 1–4 inhibitor futibatinib in Japanese patients with advanced solid tumors	19
Retracted: NQO1 promotes an aggressive phenotype in hepatocellular carcinoma via amplifying ERK‐NRF2 signaling	19
Single‐nucleotide polymorphism rs4142441 and MYC co‐modulated long non‐coding RNA OSER1‐AS1 suppresses non‐small cell lung cancer by sequestering ELAVL1	19
Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor	19
PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma	19
The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib	19
Combined administration of lauric acid and glucose improved cancer‐derived cardiac atrophy in a mouse cachexia model	19
Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models	19
Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer	19
Low‐carbohydrate diet and risk of cancer incidence: The Japan Public Health Center‐based prospective study	19
Mechanisms of resistance to immune checkpoint inhibitors	19
dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA‐repair‐defective human cancer cells	19
Single‐cell transcriptome analysis revealed the heterogeneity and microenvironment of gastrointestinal stromal tumors	19
Pathological evaluation of tumor grade for salivary adenoid cystic carcinoma: A proposal of an objective grading system	19
WEE1 inhibitor and ataxia telangiectasia and RAD3‐related inhibitor trigger stimulator of interferon gene‐dependent immune response and enhance tumor treatment efficacy through programmed death‐ligand	19
Tryptophan 2,3‐dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma	19
Casp8 acts through A20 to inhibit PD‐L1 expression: The mechanism and its implication in immunotherapy	19
ICAM1 promotes bone metastasis via integrin‐mediated TGF‐β/EMT signaling in triple‐negative breast cancer	19
circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR‐423‐5p to activate Wnt5a/Ror2 signaling	19
Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma	19
TRAF6 regulates the signaling pathway influencing colorectal cancer function through ubiquitination mechanisms	19
Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell‐derived exosome uptake by oral squamous cell carcinoma through macropinocytosis	19
Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer	19
GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expression	18
TAS‐116 (pimitespib), a heat shock protein 90 inhibitor, shows efficacy in preclinical models of adult T‐cell leukemia	18
High level of phosphatidylcholines/lysophosphatidylcholine ratio in urine is associated with prostate cancer	18
Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice	18
Expression of asporin reprograms cancer cells to acquire resistance to oxidative stress	18
Plasma extracellular vesicle microRNA‐491‐5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma	18
CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression	18
Adult T‐cell leukemia‐lymphoma as a viral disease: Subtypes based on viral aspects	18
Inhibition of microRNA let‐7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer	18
Fat mass and obesity‐associated protein regulates arecoline‐exposed oral cancer immune response through programmed cell death‐ligand 1	18
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG‐TR)	18
Guidelines for clinical evaluation of anti‐cancer drugs	18
Systematic insight into the active constituents and mechanism of Guiqi Baizhu for the treatment of gastric cancer	18
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine	18
Physiological and pathological roles of the Hippo‐YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis	18
CCL23 suppresses liver cancer progression through the CCR1/AKT/ESR1 feedback loop	18
circ_0006089 promotes gastric cancer growth, metastasis, glycolysis, and angiogenesis by regulating miR‐361‐3p/TGFB1	18
miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma	18
Lack of GD3 synthase (St8sia1) attenuates malignant properties of gliomas in genetically engineered mouse model	18
Hsa_circ_0005576 promotes osimertinib resistance through the miR‐512‐5p/IGF1R axis in lung adenocarcinoma cells	18
Clinical features and outcomes of patients with stage I multiple primary lung cancers	18
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer	18
Long‐term clinical outcomes after 12‐fractionated carbon‐ion radiotherapy for localized prostate cancer	17
The HOXC‐AS2/miR‐876‐5p/HKDC1 axis regulates endometrial cancer progression in a high glucose‐related tumor microenvironment	17
System biology analysis reveals the role of voltage‐dependent anion channel in mitochondrial dysfunction during non‐alcoholic fatty liver disease progression into hepatocellular carcinoma	17
KHDRBS3 promotes multi‐drug resistance and anchorage‐independent growth in colorectal cancer	17
TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma	17
Roles of Src family kinase, Ras, and mTOR signaling in intestinal epithelial homeostasis and tumorigenesis	17
Delta‐like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview	17
TIM‐3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways	17
Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer	17
Mitotic checkpoint regulator RAE1 promotes tumor growth in colorectal cancer	17
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study	17
Two‐year outcomes of tirabrutinib monotherapy in Waldenström’s macroglobulinemia	17
Helicobacter pylori‐induced DNA double‐stranded break in the development of gastric cancer	17
TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC	17
Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology	17
ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma	17
Biological significance of KRAS mutant allele expression in ovarian endometriosis	17
Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein‐Barr virus–positive gastric cancer	17
Depletion of tumor‐associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin	17
CD4⁺ and CD8⁺ T cells in sentinel nodes exhibit distinct pattern of PD‐1, CD69, and HLA‐DR expression compared to tumor tissue in oral squamous cell carcinoma	17
Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases	16
DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression	16
Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA	16
DDR1 functions as an immune negative factor in colorectal cancer by regulating tumor‐infiltrating T cells through IL‐18	16
Long noncoding RNA plasmacytoma variant translocation 1 promotes progression of colorectal cancer by sponging microRNA‐152‐3p and regulating E2F3/MAPK8 signaling	16
Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY	16
Tumor‐associated macrophages promote the metastasis and growth of non‐small‐cell lung cancer cells through NF‐κB/PP2Ac‐positive feedback loop	16
Lomustine and nimustine exert efficient antitumor effects against glioblastoma models with acquired temozolomide resistance	16
The inhibitory effect of human DEFA5 in growth of gastric cancer by targeting BMI1	16
SCTR hypermethylation is a diagnostic biomarker in colorectal cancer	16
Neoantigen prediction in human breast cancer using RNA sequencing data	16
Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials	16
Upregulation of S100A10 in metastasized breast cancer stem cells	16
TIMP1 promotes cell proliferation and invasion capability of right‐sided colon cancers via the FAK/Akt signaling pathway	16
Synaptonemal complex proteins modulate the level of genome integrity in cancers	16
HSP90/IKK‐rich small extracellular vesicles activate pro‐angiogenic melanoma‐associated fibroblasts via the NF‐κB/CXCL1 axis	16
Clinical significance of signal regulatory protein alpha (SIRPα) expression in esophageal squamous cell carcinoma	16
CD205⁺ polymorphonuclear myeloid‐derived suppressor cells suppress antitumor immunity by overexpressing GLUT3	15
Trends in cervical cancer incidence and mortality of young and middle adults in Japan	15
MUSASHI‐2 confers resistance to third‐generation EGFR‐tyrosine kinase inhibitor osimertinib in lung adenocarcinoma	15
AQP3‐mediated H₂O₂ uptake inhibits LUAD autophagy by inactivating PTEN	15
High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence	15